Mizuho raises target to USD 1,020 for McKesson stock

Published on 10/21/2026 at 11:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mizuho lifted its target from USD 905.00 to USD 1,020.00 on October 20, 2026. McKesson stock costs EUR 913.90 on October 21, 2026.

Analyst revision and reporting date

Mizuho lifted its McKesson target from USD 905.00 to USD 1,020.00 on October 20, 2026.
McKesson reported USD 105.38 billion in fiscal 2027 first-quarter revenue on June 30, 2026.
McKesson stock trades at EUR 913.90 at 11:03 a.m. CEST at Lang & Schwarz on October 21, 2026.
McKesson is scheduled to report fiscal 2027 second-quarter results on November 4, 2026.

McKesson, US58155Q1031, Illustration mit AI erstellt.

McKesson (ISIN US58155Q1031) is trading at EUR 913.90 at Lang & Schwarz on October 21, 2026 at 11:03 a.m. CEST. Mizuho raised its price target for the company from USD 905.00 to USD 1,020.00 on October 20, 2026, according to Markets Insider. The revision puts analyst attention on valuation ahead of McKesson's next quarterly report.

Target change raises valuation question

Mizuho kept a Neutral rating while lifting its target by USD 115.00, a 12.71 percent increase from the previous target. The note was part of a third-quarter earnings preview and cited U.S. prescription growth of 1.60 percent year over year in the quarter, according to Markets Insider.

McKesson's latest reported quarter ended June 30, 2026. Revenue reached USD 105.38 billion, up 7.70 percent from the year-earlier quarter, while diluted earnings per share were USD 5.15 and net income attributable to common shareholders was USD 614.00 million. The standardized financial statement shows operating profit of USD 1.319 billion for the period.

Three dated signals for McKesson

On August 5, 2026, McKesson reported quarterly revenue of USD 105.38 billion and earnings per share of USD 9.93 in the earnings period covered by MarketBeat. On September 3, 2026, Argus raised its target to USD 970.00, as reported by MarketBeat. On October 20, 2026, Mizuho raised its target to USD 1,020.00 from USD 905.00, according to Markets Insider.

When are the next results due?

McKesson is scheduled to report fiscal 2027 second-quarter results on November 4, 2026, according to Simply Wall St. The date gives investors a defined checkpoint for testing prescription growth, revenue and earnings against the current analyst view.

McKesson price and market scale

McKesson operates pharmaceutical and medical-supplies distribution, pharmacy services, oncology solutions and prescription technology businesses, according to McKesson. Its market capitalization was USD 120.1 billion as of October 20, 2026, while the 52-week range was USD 723.68 to USD 1,030.27. The stock was trading at EUR 913.90 at Lang & Schwarz on October 21, 2026 at 11:03 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of McKesson stock.